Coronavirus disease (COVID-19) associated mortality is higher in hematologic malignancies than in solid cancers. 1 Most published data are from single-center studies or collaborative efforts across multiple centers, primarily based in Europe. The largest survey study contains 2778 hospitalized hematologic cancer patients with COVID-19. 2